ASND — Ascendis Pharma A/S Share News
0.000.00%
Last trade - 00:00- $15.00bn
- $14.59bn
- €720.13m
Ascendis Pharma A/S expected to post a loss of €2.00 a share - Earnings Preview
Ascendis Pharma drops on $500 mln convertible debt deal
U.S. RESEARCH ROUNDUP-Coupa Software, Entergy, Nektar Therapeutics
U.S. RESEARCH ROUNDUP-DTE Energy, LTC Properties, Visteon
Ascendis Pharma A/S reports results for the quarter ended in December - Earnings Summary
U.S. RESEARCH ROUNDUP-Avanos Medical, Kraft Heinz, NetApp
U.S. RESEARCH ROUNDUP-Chargepoint Holdings, P10, Vector Group
U.S. RESEARCH ROUNDUP-Autoweb, Guild Holdings Co, Oceanfirst Financial
Ascendis Pharma A/S reports results for the quarter ended in September - Earnings Summary
U.S. STOCKS ON THE MOVE-American Eagle, Meten, Barnes & Noble, pharma stocks
Ascendis Pharma ticks down after pricing $400 mln equity offering
Ascendis jumps after FDA approves growth hormone therapy
U.S. RESEARCH ROUNDUP- Doximity, Roblox, Talos Energy
Ascendis Pharma A/S reports results for the quarter ended in June - Earnings Summary
NASDAQ RESUMED AT 04:15 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 11:56 AM
Ascendis Pharma A/S expected to post a loss of €2.23 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Beyond Meat, Masco, Nice
Ascendis Pharma A/S reports results for the quarter ended in March - Earnings Summary